Triple jeopardy for Hodgkin lymphoma survivors?
- PMID: 25035144
- PMCID: PMC4102703
- DOI: 10.1182/blood-2014-05-571646
Triple jeopardy for Hodgkin lymphoma survivors?
Abstract
In this issue of Blood, van Eggermond et al demonstrate that Hodgkin lymphoma survivors who develop a second malignancy have increased risk of developing yet a third malignancy.
Conflict of interest statement
Conflict-of-interest disclosure: The author declares no competing financial interests.
Figures
Comment on
-
Risk of multiple primary malignancies following treatment of Hodgkin lymphoma.Blood. 2014 Jul 17;124(3):319-27; quiz 466. doi: 10.1182/blood-2013-10-532184. Epub 2014 Apr 16. Blood. 2014. PMID: 24740811
References
-
- van Eggermond AM, Schaapveld M, Lugtenburg PJ, et al. Risk of multiple primary malignancies following treatment of Hodgkin lymphoma. Blood. 2014;124(3):319–327. - PubMed
-
- Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute; 2014.
-
- Hodgson DC, Gilbert ES, Dores GM, et al. Long-term solid cancer risk among 5-year survivors of Hodgkin’s lymphoma. J Clin Oncol. 2007;25(12):1489–1497. - PubMed
-
- Travis LB, Gospodarowicz M, Curtis RE, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst. 2002;94(3):182–192. - PubMed
-
- Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290(4):465–475. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
